Comparison of Oncological Disease Rates in Health Board Reports Based on the National Regulations
Duygu Bayir Garbioglu1, Arif Garbioglu21Department of Medical Oncology, Zonguldak Bulent Ecevit University Faculty of Medicine, Zonguldak, Türkiye, 2Zonguldak Forensic Medicine Branch Office, Council of Forensic Medicine, Zonguldak, Türkiye
Objectives: We aimed to identify the demographic characteristics of oncological patients applying for a Health Board Report (HBR), the differences between the evaluation criteria in the oncology section of disability and incapability regulations and the discrepancies within the disability regulation in the field of oncology leading to potential loss of rights as well as identifying the possible interpretation differences and offering solutions to address them. Methods: Sociodemographic data of 375 subjects who applied for a HBR between 2019 and 2023, including the reason for applying to the health board, and the oncology section score they obtained in accordance with the disability regulations is recorded. Results: A comparison of the disability and incapability regulations showed that 11.5% of the patients experienced loss of rights in accordance with the current regulations. The oncological scores of stage 1, 2 patients increased according to the current regulations while there was a reduction in the oncological scores of stage 3 patients (p<0.001). Conclusion: An update in the current regulation, considering the gaps or the aspects that might have been perceived differently by clinicans will help prevent the loss of rights for patients who apply to the Health Board due to disabilities. Keywords: Cancer, disability, regulations, incapability
Cite This Article
Garbioglu D, Garbioglu A. Comparison of Oncological Disease Rates in Health Board Reports Based on the National Regulations. EJMI. 2023; 7(4): 454-459
Corresponding Author: Duygu Bayir Garbioglu